Abstract
Transcription initiation involves the coordinated activities of large multimeric complexes, but little is known about their biogenesis. Here we report several principles underlying the assembly and topological organization of the highly conserved SAGA and NuA4 co-activator complexes, which share the Tra1 subunit. We show that Tra1 contributes to the overall integrity of NuA4, whereas, within SAGA, it specifically controls the incorporation of the de-ubiquitination module (DUB), as part of an ordered assembly pathway. Biochemical and functional analyses reveal the mechanism by which Tra1 specifically interacts with either SAGA or NuA4. Finally, we demonstrate that Hsp90 and its cochaperone TTT promote Tra1 de novo incorporation into both complexes, indicating that Tra1, the sole pseudokinase of the PIKK family, shares a dedicated chaperone machinery with its cognate kinases. Overall, our work brings mechanistic insights into the assembly of transcriptional complexes and reveals the contribution of dedicated chaperones to this process.
Subject terms: Chaperones, Transcription factors, Proteomics, Gene expression, Transcription
Transcription initiation involves the coordinated assembly and activity of large multimeric complexes. Here the authors report on the chaperone-mediated ordered assembly of the SAGA and NuA4 transcription co-activator complexes in fission yeast, providing insight into the de novo assembly of transcriptional complexes and the contribution of dedicated chaperones to this process.
Introduction
A critical step in gene expression is transcription initiation, which is controlled by many factors that typically function as part of multimeric complexes. Genetic, biochemical and structural evidence indicates that their subunits form distinct modules with specific functions. Numerous studies have characterised their activities and regulatory roles in gene expression. In contrast, much less is known about how these complexes assemble, which chaperones are required, and whether their assembly can be modulated to control or diversify their functions. Deciphering these principles is important to fully understand their structural organisation, function and allosteric regulation1. Notably, chromatin-modifying and -remodelling complexes often share functional modules and therefore probably require dedicated mechanisms and chaperones for their proper assembly2.
One such complex, the Spt-Ada-Gcn5 acetyltransferase (SAGA) co-activator, bridges promoter-bound activators to the general transcription machinery. In yeast, SAGA is composed of 19 subunits, which are organised into five modules with distinct regulatory roles during transcription3,4. These include histone H3 acetylation (HAT), histone H2B de-ubiquitination (DUB) and loading of TBP onto the promoter. A fourth module consists of a set of core components that scaffold the entire complex, most of which are shared with the general transcription factor TFIID. Finally, the largest SAGA subunit, Tra1, is shared with another transcriptional co-activator complex, yeast NuA4, which also contains a HAT module that preferentially targets histone H4 and the H2A.Z variant5. Tra1 directly interacts with a diverse range of transcription factors, and recruits SAGA and NuA4 to specific promoters upon activator binding (reviewed in refs. 6,7).
Yeast Tra1 and its human ortholog, TRRAP, belong to a family of atypical kinases, the phosphoinositide 3 kinase-related kinases (PIKKs), but lack catalytic residues and are thus classified as pseudokinases8–10. The reason for the evolutionary conservation of a typical PIKK domain architecture within Tra1 orthologs is not known. Genetic and biochemical studies indicate that Tra1 primary role is to mediate the transactivation signal from activators by recruiting SAGA and NuA4 to chromatin. It has been difficult, however, to delineate the specific contribution of Tra1 to SAGA and NuA4 architecture and activities because, to date, no clear separation-of-function alleles exist. Indeed, the mechanism by which Tra1 interacts differentially with SAGA and NuA4 remains elusive.
The fission yeast Schizosaccharomyces pombe provides a unique opportunity to address this issue because it has two paralogous proteins, Tra1 and Tra2, and each has non-redundant roles that are specific for SAGA and NuA4, respectively11. Within SAGA, Tra1 has specific regulatory roles and does not contribute to its overall assembly11, consistent with its peripheral position in the recent cryo-electron microscopy structure of SAGA from the budding yeast Pichia pastoris12. In contrast, a recent partial structure of the yeast NuA4 complex indicates that Tra1 occupies a more central position13. However, little is known about how Tra1 incorporates into the SAGA and NuA4 complexes, whether it involves similar or distinct mechanisms, and which chaperone or assembly factors are required.
Here, we show that, in S. pombe, Tra1 and Tra2 require Hsp90 and its cochaperone, the Triple-T complex (TTT), for their de novo incorporation into SAGA and NuA4, respectively. Furthermore, proteomic, biochemical and genetic approaches identify the residues mediating Tra1 specific interaction with SAGA. Notably, we demonstrate that Tra1 contacts a surprisingly small region of the core subunit Spt20, which is both necessary and sufficient for Tra1 interaction with SAGA. Kinetic analyses of nascent Tra1 incorporation reveal that it promotes the integration of the DUB module, uncovering an ordered pathway of SAGA assembly. Finally, in contrast to the specific role of Tra1 in SAGA architecture, we show that Tra2 has a general scaffolding role in NuA4 assembly. Overall, our work brings mechanistic insights into the assembly and modular organisation of two important transcriptional co-activator complexes.
Results
The TTT subunit Tti2 contributes to Tra1 and Tra2 functions
Previous work in mammalian cells revealed that the Hsp90 cochaperone TTT stabilises PIKKs, including TRRAP, the human ortholog of yeast Tra114–19. Three specific subunits, Tel2, Tti1 and Tti2, define the TTT complex in S. pombe, Saccharomyces cerevisiae and human cells (Supplementary Data 1)16,20,21. Some TTT subunits interact physically and genetically with Tra1 in S. cerevisiae and S. pombe11,20–23. Fission yeasts have two paralogous genes, tra1 and tra2, and each has non-redundant roles that are specific for SAGA or NuA4, respectively11. S. pombe thus offers a unique opportunity to study the specific contribution of TTT and Tra1 to SAGA and NuA4 organisation and function.
In human cells, TTI2 is critical for the stability of both TEL2 and TTI1 at steady state17, in agreement with its stable binding to the TTT complex. We thus focused our investigations on Tti2, which we confirmed interacts with both Tra1 and Tra2 in S. pombe (Supplementary Data 1). Like Tti2, Tra2 is essential for viability, whereas tra1Δ mutants are viable11,22. We thus developed a strategy based on inducible CreER-loxP-mediated recombination to generate conditional knockout alleles of tti2 (tti2-CKO) and tra2 (tra2-CKO). These strains showed β-estradiol-induced loss of Tti2 or Tra2 expression, which correlated with progressive proliferation defects, but no obvious decrease in cell viability, at least within the time frame analysed (Supplementary Figs. 1, 2). Based on these observations, tti2-CKO and tra2-CKO strains were induced with β-estradiol for 18 and 21 h, respectively, before further analysis.
We then performed genome-wide expression analyses of DMSO- and β-estradiol-treated tti2-CKO and tra2-CKO cells, compared with a creER control strain treated identically. We also analysed tra1Δ mutants that were compared with a wild-type strain. Differential expression analysis revealed both specific and overlapping changes in each mutant (Fig. 1a–d; Supplementary Fig. 3). Specifically, gene expression changes correlated positively between tti2-CKO and tra2-CKO mutants, as well as between tti2-CKO and tra1Δ mutants (Fig. 1a). In contrast, no correlation was observed between tra2-CKO and tra1Δ mutants (Fig. 1a), as expected from their specific, non-redundant roles within either NuA4 or SAGA11. A Venn diagram of the most differentially expressed genes (FC ≥ 1.5, P ≤ 0.01) shows the extent of the overlap between all three mutants (Fig. 1b). Remarkably, over half of the Tti2-dependent genes (105/184) are also regulated by Tra1 (25), Tra2 (72) or both Tra1 and Tra2 (8), suggesting that TTT has an important role in Tra1- and Tra2-dependent gene expression in S. pombe.
Hierarchical clustering of all differentially expressed genes (P ≤ 0.01) identified at least seven distinct clusters (Supplementary Fig. 3b, c). These include a large cluster of transcripts in which levels decrease in both tti2-CKO and tra2-CKO mutants (Cluster 2, 527 genes), and a smaller one in which levels decrease in both tti2-CKO and tra1Δ mutants (Cluster 6, 172 genes). We independently measured the expression of genes from each cluster using quantitative RT-PCR analyses and confirmed that SPCC1884.01 and SPCAC977.12 levels (Cluster 2) decrease in both tti2-CKO and tra2-CKO mutants (Fig. 1d), while SCC569.05c and gst2 levels (Cluster 6) decrease in both tti2-CKO and tra1Δ mutants (Fig. 1c).
In S. cerevisiae, elegant biochemical and functional studies established that the primary role of Tra1 is to mediate activator-dependent recruitment of SAGA or NuA4 to specific promoters24–30. We thus evaluated the effect of Tti2 on the binding of the SAGA subunit Spt7 and the NuA4 subunit Epl1 to specific promoters, using chromatin immunoprecipitation (ChIP). Upon depletion of Tti2, we observed reduced occupancy of Spt7 at the pho84 and mei2 promoters and of Epl1 at the ssa2 promoter, despite normal steady-state levels (Fig.1e, f).
In conclusion, we accumulated functional evidence that Tti2, likely as part of the TTT complex, contributes to the regulatory activities of Tra1 and Tra2 in gene expression. Therefore, similar to their active kinase counterparts, the Tra1 and Tra2 pseudokinases require the TTT cochaperone to function.
Tti2 promotes Tra1 and Tra2 assembly into SAGA and NuA4
These observations prompted us to test whether Tti2, as an Hsp90 cochaperone, promotes Tra1 and Tra2 incorporation into SAGA and NuA4, respectively, as shown for human mTOR and ATR-containing complexes16,18. For this, we affinity purified SAGA and NuA4 upon tti2 conditional deletion. Silver staining and quantitative MS analyses revealed a tenfold reduction of Tra1 from SAGA when Tti2 is depleted, as compared with control conditions (Fig. 2a). Similarly, we observed about a twofold reduction of Tra2 levels from NuA4 (Fig. 2b).
We next tested if Tti2 promotes the de novo incorporation of Tra1 into SAGA or, rather, prevents its disassembly. For this, we took advantage of the viability of tra1Δ mutants and disrupted the tra1 promoter with a transcription terminator sequence flanked by loxP sites (RI-tra1, Supplementary Fig. 4a). With this allele, CreER-mediated recombination allows the inducible expression of Tra1 at endogenous levels. As a proof-of-principle, β-estradiol addition to RI-tra1 strains suppresses their growth defects in conditions of replicative stress, using hydroxyurea (HU) (Supplementary Fig. 4b), to which tra1Δ mutants are sensitive11. Purification of SAGA from β-estradiol-treated RI-tra1 cells showed a time-dependent, progressive increase of newly synthesised Tra1 (neo-Tra1) in Spt7 purification eluates, validating this approach for monitoring Tra1 de novo incorporation into SAGA (Fig. 3a). However, to conditionally deplete TTT from RI-tra1 cells, we needed to develop a different strategy from the CreER-loxP-mediated knockout used so far. We attempted to tag Tti2 with an auxin-inducible degron (AID), but observed substantial destabilization even before adding the plant hormone auxin. In contrast, targeting another TTT complex subunit (Supplementary Data 1), Tel2, caused efficient and auxin-dependent degradation (Supplementary Fig. 5a–d). We then analysed SAGA purifications from RI-tra1 tel2-AID cells using silver staining (Fig. 3b) and quantitative MS analyses (Fig. 3d). Both approaches showed decreased interaction between newly synthesised Tra1 and affinity purified Spt7 in cells partially depleted of Tel2. These results demonstrate that TTT contributes to the de novo incorporation of Tra1 into the SAGA complex.
Experiments with human cells suggested that TTT functions as an adaptor recruiting the HSP90 chaperone specifically to PIKKs16,19,31. We thus determined if Tra1 incorporation into SAGA requires Hsp90. We first tested the effect of conditionally inactivating Hsp90 on SAGA subunit composition at steady state. For this, we affinity purified Spt7 from hsp90–26 temperature-sensitive mutants grown at either permissive or restrictive temperature32. Silver staining analysis showed that Hsp90 inactivation causes a specific decrease of Tra1 in Spt7 purification eluates (Supplementary Fig. 6). We next asked whether Hsp90 contributes to de novo incorporation of Tra1 into SAGA. However, CreER cytoplasmic sequestration depends on a functional Hsp90. We thus used an hsp90–201 strain, which harbors a weaker Hsp90 mutant allele33. Silver staining (Fig. 3c) and quantitative MS analyses (Fig. 3d) revealed a decrease of newly synthesised Tra1 in SAGA purified from hsp90–201 mutants, as compared with wild-type cells. Although the observed effect is modest in this hypomorphic mutant, this observation supports the conclusion that Hsp90, like TTT, contributes to the de novo assembly of Tra1 into SAGA. Altogether, our results indicate that TTT acts as an Hsp90 cochaperone promoting the assembly of Tra1 into SAGA and likely Tra2 into NuA4. Therefore, pseudokinases and kinases of the PIKK family share a specific, dedicated chaperone machinery for their maturation and incorporation into active complexes.
Tra1 and Tra2 have distinct roles within SAGA and NuA4
We noted that the loss of TTT affected SAGA and NuA4 differently. Upon Tti2 depletion, the decrease of Tra1 does not affect the overall migration profile of SAGA, similar to what we observed in tra1Δ mutants (Fig. 2a)11. In contrast, the effect of Tti2 on Tra2 incorporation into NuA4 is less pronounced, but appears to cause a global decrease in the amount of purified NuA4 subunits (Fig. 2b), without affecting total protein content (Supplementary Fig. 1f). Alternatively, the bait used for this purification, the Mst1 HAT subunit, might dissociate from the rest of the complex upon tti2 deletion and loss of Tra2 from NuA4. Finally, we noticed reduced Mst1 levels in total extracts from Tti2-depleted cells (Fig. 2b), possibly accounting for the decrease in the amount of purified NuA4.
To directly evaluate the effect of Tra2 on NuA4 subunit composition, we purified NuA4 upon tra2 deletion, using tra2-CKO cells. For this, we affinity purified either Epl1, which anchors the HAT module to the rest of NuA4 in S. cerevisiae34, or Vid21, whose S. cerevisiae ortholog Eaf1 forms a platform for NuA4 assembly35. Silver staining and quantitative MS analyses of affinity purified Mst1, Epl1 and Vid21 revealed that each interact with a similar set of 13 proteins, which, altogether, define the NuA4 complex from S. pombe (Supplementary Fig. 7a–c), confirming and extending results from a previous study21. Then, upon Tra2 conditional depletion, we observed an overall decrease in the amount of purified NuA4 in both Epl1 and Vid21 purification eluates (Fig. 4a). Quantitative MS analyses of Vid21 purification eluates confirmed an overall decrease of all 13 NuA4 subunits when Tra2 is depleted (Fig. 4b). Importantly, cell viability and total protein content are not affected at this time point (Supplementary Fig. 2e, f; Fig. 4a). Furthermore, control SAGA purifications suggested that other chromatin-bound complexes can be efficiently extracted and purified upon Tra2 depletion (Supplementary Fig. 8). Altogether, these results indicate that, in contrast to Tra1 in SAGA, Tra2 contributes to the scaffolding and stabilisation of the entire NuA4 complex. Such distinct architectural roles provide a functional validation of the recent structural studies of yeast SAGA and NuA4, which showed that Tra1 occupies a peripheral position within SAGA and a more central position within NuA412,13,36–38.
Mechanism of Tra1 specific interaction with SAGA
We next sought to determine how Tra1 interacts specifically with SAGA, taking advantage of the viability of tra1 mutants in S. pombe and guided by the most recent cryo-electron microscopy structure of SAGA from P. pastoris (Fig. 5a)12. Resolution of the secondary structure elements of Tra1 bound to SAGA identified a narrow and highly flexible hinge region that was suggested to form the major, if not the single interaction surface between Tra1 and the rest of the complex12. This region is located near the start of the Tra1 FAT domain and consists of about 50 residues that fold into three distinct α-helices (H1-H3, Fig. 5a). Multiple alignments of Tra1 orthologs from yeast, invertebrate and vertebrate species indicate that this region is conserved throughout eukaryotes (Fig. 5a). Interestingly, the homologous region of S. pombe Tra2, which is only present in NuA4, is more divergent, suggesting that this region might dictate SAGA binding specificity.
Deletion of a few helices within Tra1 can cause important structural rearrangements and destabilise the protein30. Thus, to determine the contribution of this 50-residue region to Tra1-SAGA interaction, we swapped them with those from the closest homolog of Tra1, S. pombe Tra2, which does not interact with SAGA11. We also introduced the corresponding sequence from S. cerevisiae Tra1 (Fig. 5b), which is shared between SAGA and NuA4. We first verified that both Tra1-SpTra2 and Tra1-ScTra1 mutant proteins are expressed at levels similar to those of wild-type Tra1 (Fig. 5c). In contrast, silver staining and quantitative MS analyses revealed that the Tra1-SpTra2 hybrid is not detectable in Spt7 purifications, whereas normal levels of the Tra1-ScTra1 hybrid are observed (Fig. 5c). Similarly, a Tra1-mTOR hybrid protein is unable to copurify with SAGA (Supplementary Fig. 9a), consistent with human mTOR assembling into unrelated complexes, TORC1 and TORC2. Importantly, quantitative MS analyses show that both Tra1-SpTra2 and Tra1-ScTra1 hybrid mutant proteins efficiently copurify with Tti2 (Supplementary Fig. 9b). Thus, this region does not affect Tra1 binding to TTT and the Tra1-SpTra2 mutant protein is recognised by its cochaperone, despite being unable to interact with SAGA.
Phenotypic analyses of tra1-Sptra2 and tra1-Sctra1 strains showed that tra1-Sptra2 mutants are sensitive to HU and caffeine, similar to tra1Δ mutants, whereas tra1-Sctra1 strains show no growth defects, as compared with wild-type cells (Fig. 5d). RNA-seq analyses of tra1-Sctra1 and tra1-Sptra2 mutants revealed that the transcriptomic changes observed in tra1-Sptra2 and tra1Δ mutants correlate well (r2 = 0.58), as compared with wild-type cells (Fig. 5e). In contrast, tra1-Sctra1 mutants show little changes, correlating poorly with tra1Δ mutants (r2 = 0.16) (Fig. 5f).
To conclude, a 50-residue region from S. cerevisiae Tra1 complements the orthologous region from S. pombe Tra1, likely because S. cerevisiae Tra1 is present in both SAGA and NuA4. In contrast, the paralogous region from S. pombe Tra2 diverged such that it cannot interact with SAGA. Whether this region of Tra2 is responsible for its specific integration into NuA4 remains to be determined. Altogether, structural, biochemical and functional evidence demonstrates that Tra1 directly contacts SAGA through a restricted, 50-residue region located at the beginning the FAT domain. This region of Tra1 consists of three α-helices that fold into a cup-shaped structure (Fig. 5a)12, which we thus coined the Cup SAGA Interacting (CSI) region of Tra1.
The SAGA subunit Spt20 anchors Tra1 into the SAGA complex
Patrick Schultz’s laboratory reported that the Tra1-SAGA hinge accommodates a putative α-helix belonging to a SAGA subunit other than Tra112. This observation encouraged us to identify the residues forming the other side of the hinge and directly contacting the Tra1 CSI region. Besides Tra1, 18 subunits form the S. pombe SAGA complex39. Genetic, biochemical and structural evidence suggests that of these, Ada1, Taf12 and Spt20 are candidates to anchor Tra1 within SAGA11,12,36,37,40,41. Silver staining analyses revealed that Tra1 is undetectable in SAGA purified from spt20Δ mutants, without any other visible changes in its overall migration profile (Fig. 6a). Spt20 is therefore essential for Tra1 incorporation into SAGA.
S. pombe Spt20 is 474-residue long and comprises an N-terminal half that contains several conserved regions, named homology boxes (HB)42, and a C-terminal low-complexity region (LCR) (Fig. 6b). Deletion of the Spt20 N-terminal half (residues 1–255) abolished its interaction with SAGA (Supplementary Table 1), indicating that this portion of Spt20 mediates its integration into the complex. Silver staining analyses of SAGA purified from mutants that remove various lengths of the Spt20 C-terminal LCR identified a short region of 11 residues that is crucial for Tra1-SAGA interaction (Fig. 6c). Quantitative MS analyses confirmed that Tra1 does not interact with SAGA in spt20–290 mutants, in which residues 291–474 are deleted, whereas normal levels of Tra1 are detected in spt20–300 mutants, in which residues 301–474 are deleted (Fig. 6c).
Structure prediction identified an α-helix in this region, which we coined the head interacting with Tra1 (HIT) (Fig. 6d). Silver staining and quantitative MS analyses of SAGA purified from mutants in which the Spt20 HIT region is deleted (spt20-HITΔ) confirmed its importance for Tra1 interaction (Fig. 6e). Similarly, mutating the HIT identified four residues, FIEN, that are important for Tra1 incorporation into SAGA, whereas the four positively charged RRKR residues contribute less (Fig. 6e). We verified that all Spt20 truncation, deletion and point mutants are expressed at levels comparable to those of wild-type Spt20 (Supplementary Fig. 10a) and, importantly, are present in purified SAGA complexes (asterisk in Fig. 6c, e). Furthermore, in all these mutants, Tra1 is expressed at levels similar to those observed in WT cells (Supplementary Fig. 10b). This observation suggests that unassembled Tra1 is stable, contrary to core SAGA subunits40, and folded correctly, in agreement with the similarity of Tra1 structures whether alone or within SAGA7.
We next evaluated the phenotype of spt20-HIT mutant strains. Similar to tra1Δ mutants, spt20-HITΔ and spt20-FIEN mutants are sensitive to HU, whereas spt20-RRKR show milder defects, as compared with wild-type cells (Fig. 6f). RNA-seq analyses of spt20Δ and spt20-HITΔ mutants revealed similar transcriptomic changes to those observed in tra1-Sptra2 and tra1Δ mutants, as compared with a wild-type strain. Comparing spt20-HITΔ with spt20Δ mutants revealed that the Spt20 HIT region contributes to the expression of only a subset of Spt20-dependent genes (r2 = 0.35) (Fig. 6g), consistent with the HIT region being specifically involved in Tra1 interaction. Indeed, we observed a better correlation between spt20-HITΔ and tra1Δ mutants (r2 = 0.44) (Fig. 6h). Remarkably, the strongest correlation was obtained when comparing spt20-HITΔ with tra1-Sptra2 mutants (r2 = 0.62) (Fig. 6i), i.e., strains in which the hinge is mutated on either side of the same interaction surface. Altogether, these biochemical and functional approaches identified a narrow region of Spt20 that is necessary to integrate Tra1 into SAGA, likely by direct interaction with the Tra1 CSI region.
Spt20 is necessary for Tra1 incorporation in S. cerevisiae
Such a restricted and specific interaction surface might have appeared specifically in S. pombe, because Tra1 and Tra2 diverged enough to interact exclusively with either SAGA or NuA4. We thus sought to identify a homologous Spt20 HIT region in S. cerevisiae, in which a single Tra1 protein can interact with both SAGA and NuA4.
Although S. pombe and S. cerevisiae Spt20 orthologs diverged substantially42, their overall domain organisation is similar. We thus focused our mutational analysis of S. cerevisiae Spt20 to a region located between the HB and the LCR (Fig. 7a). Silver staining analyses of S. cerevisiae SAGA purified from mutants that remove various lengths of the Spt20 C-terminal LCR identified a short region of 18 residues (474–492) that is critical to incorporate Tra1 into SAGA (Fig. 7b). Quantitative MS analyses confirmed the importance of this region for Tra1 interaction with SAGA. Indeed, <3% of Tra1 is detected in Spt7 purification eluates from spt20–474 mutants, as compared with spt20–492 mutants or WT controls (Fig. 7c). Western blotting of Spt20 truncation mutants confirmed that each mutant is still present in SAGA (Fig. 7d). Finally, secondary structure prediction identified a α-helix in this region (Fig. 7a), further arguing that the Spt20 HIT region is functionally and structurally conserved between S. pombe and S. cerevisiae.
The Spt20 HIT region is sufficient for Tra1 interaction
We next asked whether the Spt20 HIT region is sufficient to interact with Tra1. For this, a peptide of about 50 residues encompassing the HIT region from either S. pombe or S. cerevisiae was immobilised on a column, through fusion to GST, and incubated with S. pombe protein extracts prepared from wild-type, tra1-Sptra2 and tra1-Sctra1 strains. We observed that both recombinant Spt20 HIT fragments specifically pull-down wild-type S. pombe Tra1, as compared with GST alone (lanes 1 vs. 2, Fig. 7e). Similar levels of the Tra1-ScTra1 hybrid are recovered on the GST-HIT column (lanes 5 vs. 6, Fig. 7e). Consistent with our in vivo observations that the Tra1 CSI region mediates this interaction, lower amounts of the Tra1-SpTra2 hybrid mutant are recovered on the GST-HIT column (lane 3 vs. 4, Fig. 7e). Overall, these experiments indicate that the Spt20 HIT region folds into a α-helix that is both necessary and sufficient for anchoring Tra1 in two highly divergent yeast species. We have thus elucidated the structural elements forming the narrow hinge and mediating the specific contact between Tra1 and the rest of SAGA. Notably, only a few residues are involved, in agreement with the peripheral position of Tra1 within SAGA12.
Tra1 orchestrates an ordered pathway for SAGA assembly
Throughout this study, quantitative MS analyses of S. pombe SAGA purified from various mutants revealed an unexpected finding: the amount of DUB module subunits within SAGA consistently decreased when Tra1 is unassembled. For instance, we measured a reproducible decrease of both Sgf73 and Ubp8 in Spt7 purified from tra1Δ or β-estradiol-treated tti2-CKO cells, as compared with isogenic controls (Fig. 8a, b). Similarly, mutating either side of the hinge reduces the amount of both Sgf73 and Ubp8 in SAGA purifications, as observed in spt20–290, spt20-HITΔ, spt20-FIEN and tra1-Sptra2 mutants (Hinge in Fig. 8a, b) (Supplementary Table 2). In contrast, the levels of Sgf73 and Ubp8 do not change in Spt7 purifications from spt20–300, spt20-RRKR and tra1-Sctra1 strains, in which Tra1 incorporates into SAGA (Supplementary Table 2). The other two DUB subunits, Sgf11 and Sus1, are ~10 kDa, and therefore less reliably quantified by MS. The reproducibility of this effect across distinct mutants that all affect Tra1 incorporation suggested that Tra1 promotes assembly of the DUB module into SAGA.
We first asked whether, conversely, the DUB module stabilises Tra1 within SAGA. In S. cerevisiae, Sgf73 is critical to anchor the DUB module into SAGA43. Mass spectrometry analyses confirmed that, in S. pombe sgf73Δ mutants, the DUB subunits Ubp8, Sgf11 and Sus1 are absent from SAGA purifications (Supplementary Table 3). In contrast, silver staining and MS analyses of SAGA indicated that Spt20 and Tra1 assembly were unaffected in sgf73Δ mutants (Fig. 8c). Altogether, these results suggest that SAGA assembly follows a unidirectional, ordered pathway, in which Spt20 anchors Tra1, which then stabilises the DUB module.
To test this hypothesis directly, we purified SAGA from RI-tra1 strains (Fig. 3a), in which endogenous Sgf11 is tagged with a MYC epitope. We then concomitantly monitored the assembly kinetics of both newly synthesised Tra1 and the DUB module. We first confirmed that Sgf11 interacts less strongly with Spt7 in tra1Δ mutants or untreated RI-tra1 cells, as compared with control conditions (lanes 2 and 3 vs. 6, Fig. 8d). We then observed a progressive increase in the amount of Sgf11 interacting with Spt7 upon β-estradiol treatment and de novo Tra1 incorporation (Fig. 8d). Quantification of four independent experiments confirmed the reproducibility of these observations (Fig. 8e). Supporting the existence of an ordered assembly pathway, comparing the relative levels of Sgf11 and Tra1 in SAGA at 4 h of induction shows that integration of the DUB module is slightly delayed compared with Tra1.
Overall, we accumulated functional and biochemical evidence supporting a model in which nascent Tra1 is recognised by the Hsp90 cochaperone TTT, possibly to catalyse its folding into a mature conformation. Tra1 is assembled by direct interaction with a small region of Spt20 and then promotes the incorporation of the DUB module within SAGA (Fig. 8f).
Discussion
Many chromatin and transcription regulators function within large multimeric complexes. Deciphering the principles that govern their assembly is key to understanding their structural organisation, function and regulation. Our work brings several mechanistic insights into the de novo assembly and modular organisation of two such complexes, SAGA and NuA4. First, the Hsp90 cochaperone TTT promotes Tra1 and Tra2 incorporation into SAGA and NuA4, respectively. Second, structure-guided mutational analyses elucidated the specificity of Tra1 interaction with SAGA vs. NuA4. The topology of the Tra1-SAGA interaction surface consists of a small region of the Tra1 FAT domain contacting a single α-helix of the core subunit Spt20. Third, in contrast to the general role of Tra2 in NuA4 complex formation, Tra1 specifically controls the incorporation of the DUB module into SAGA, uncovering an ordered pathway of SAGA assembly.
We show here that SAGA and NuA4 require a dedicated chaperone machinery to be fully assembled. A recent study in human cells showed that both the TFIID-specific subunit TAF5 and its SAGA-specific paralog TAF5L require a specific chaperone, the CCT chaperonin, for their incorporation into pre-assembled modules44. Our work therefore contributes to the emerging concept that dedicated chaperone machineries and ordered pathways control the de novo assembly of chromatin- and transcription-regulatory complexes.
Studies in mammals revealed that the pleiotropic HSP90 chaperone is specifically recruited to PIKKs by a dedicated cochaperone, the TTT complex, to promote their stabilisation and assembly into active complexes14–19. In contrast, the effect of TTT on the Tra1 pseudokinase, the only inactive member of the PIKK family, is less characterised. TTT stabilises TRRAP in human cells14,17–19 and several studies reported physical and genetic interaction between Tra1 and TTT components in yeast11,20–23. We accumulated functional and biochemical evidence that, in S. pombe, Hsp90 and TTT promote the incorporation of Tra1 and Tra2 into the SAGA and NuA4 complexes, respectively. In agreement, we found that the TTT subunit Tti2 contributes to Tra1- and Tra2-dependent gene expression, as well as SAGA and NuA4 promoter recruitment. Therefore, although Tra1 is the sole catalytically inactive member of the PIKK family, it shares a dedicated chaperone machinery with active PIKK kinases for its folding, maturation, and assembly into a larger complex.
Phylogenetic analyses of PIKK orthologs in various organisms indicate that the Tra1 pseudokinase appeared early in the eukaryotic lineage, concomitantly with other PIKKs (our unpublished observations). As expected for a pseudokinase, catalytic residues diverged substantially. However, Tra1 orthologs retain the distinctive domain architecture of all PIKKs, which consists of a long stretch of helical HEAT repeats, followed by TPR repeats forming the FAT domain, preceding the FRB, PI3K-like and FATC domains. It is thus tempting to speculate that the requirement of PIKKs for a dedicated cochaperone explains the selection pressure that is observed on the sequence and domain organisation of Tra1, in the absence of conserved, functional catalytic residues. For example, the short, highly conserved C-terminal FATC domain loops back close to the active site and is critical for mTOR kinase activity45. Similarly, we found that the FATC domain is essential for Tra1 incorporation into SAGA (our unpublished observations), perhaps through allosteric control of the folding and positioning of the CSI region, which directly contacts SAGA.
Biochemical and functional evidence suggested that the Tra1 pseudokinase serves as a scaffold for the assembly and recruitment of the SAGA and NuA4 complexes to chromatin. S. pombe provides a unique opportunity to better understand its roles within each complex because it has two paralogous proteins, Tra1 and Tra2, and each has non-redundant functions that are specific for SAGA and NuA4, respectively11. Our work indicates that, within SAGA, Tra1 has specific regulatory roles and does not scaffold the entire complex but, rather, controls the assembly of the DUB module. In contrast, Tra2 contributes to the overall integrity of NuA4. In agreement, the most recent structures of yeast SAGA and NuA4 showed different positions of Tra1 relative to other subunits. Within SAGA, Tra1 localises to the periphery of the complex12 and directly interacts with Spt20 (Figs. 6, 7), whereas it occupies a more central position within NuA4 and contacts several different subunits13. We therefore anticipate that the single Tra1 protein found in most other eukaryotic organisms has distinct architectural roles between SAGA and NuA4 and functions as a scaffold only within the NuA4 complex.
However, what determines the distribution of Tra1 between SAGA and NuA4 remains elusive. One possibility is that SAGA- and NuA4-specific subunits compete for binding to the Tra1 CSI region. This mechanism would be similar to that described for mTOR assembly into the TORC1 and TORC2 complexes. Their structures revealed that the TORC1-specific subunit Raptor and the TORC2-specific subunit Rictor compete for binding to the same HEAT repeats of mTOR46,47. Similarly, electron microscopy and cross-linking coupled to MS indicate that the Tra1 FAT domain makes extensive contacts with several distinct NuA4 subunits13,38. We speculate that these interactions would sterically hinder the binding of Spt20 to the three α-helices forming the Tra1 CSI region (Fig. 5a). Higher resolution structures and further biochemical studies are required to test this hypothesis and explain why Tra1 binding to SAGA and NuA4 is mutually exclusive.
In marked contrast with S. cerevisiae and mammals, a tra1Δ deletion mutant is viable in S. pombe, enabling detailed biochemical and genetic studies that are more difficult in other organisms6. Taking advantage of this opportunity, we made significant progress in our understanding of the topological organisation of the Tra1-SAGA interface. The latest structure of SAGA clearly shows that Tra1 occupies a peripheral position and interacts with the rest of the complex through a narrow and flexible surface interaction, forming a hinge12. Our structure–function analyses identified the residues that constitute the hinge. Specifically, a small 50-residue region of the large Tra1 protein dictates the specificity of its interaction with SAGA. The homologous region from S. pombe Tra2 diverged such that it cannot interact with SAGA. Conversely, within the hinge, a density predicted to form a α-helix not attributable to Tra1 was observed at the threshold used to resolve Tra1 secondary structure elements12. Here, we demonstrate that a short portion of Spt20, which we named the HIT region, is both necessary and sufficient to anchor Tra1 within SAGA. The strong dependency of Tra1 on Spt20 HIT region (Figs. 6, 7) suggests that these residues constitute the main interface between Tra1 and the rest of SAGA, allowing the construction of unique separation-of-function mutations for phenotypic and functional analyses. The exact roles of Tra1/TRRAP have been challenging to study genetically because of its presence in both SAGA and NuA430 and of its essential roles in S. cerevisiae proliferation or during mouse early embryonic development9,48. As shown in S. cerevisiae (Fig. 7), identifying the residues mediating Tra1-SAGA interaction paves the way for addressing this issue.
Previous work suggested that Ada1 contributes to Tra1 incorporation into SAGA40 and that Taf12 might form part of the hinge12,36. Biochemical and functional evidence indicates that these subunits heterodimerize, as part of an octamer of histone folds forming the structural core of SAGA, analogous to that of TFIID2. Even if specific residues of Ada1 and/or Taf12 directly contact Tra1 and stabilise its interaction with SAGA, we predict that their contribution will be minor, at least under the experimental conditions tested here. Our results demonstrate that the Spt20 HIT region is both necessary and sufficient for Tra1 incorporation into SAGA, in two highly divergent yeast species. Importantly, quantitative MS analyses show that Ada1 and Taf12 incorporation into SAGA does not require Spt20 (Supplementary Table 1). Nonetheless, it is formally possible that deleting or mutating the Spt20 HIT region affects Ada1 and/or Taf12 conformation and position within SAGA, such that their putative contacts with Tra1 are weakened.
Finally, analysis of SAGA conformations revealed continuous movements between Tra1 and the rest of SAGA, around the hinge12. This observation may have important implications for the allosteric regulation of SAGA activities. Indeed, such structural flexibility suggests that the interaction between Tra1 and Spt20 is dynamic. Therefore, depending on the conformation of the entire complex, Tra1 might directly interact with subunits other than Spt20, including Ada1 and Taf12. Understanding the molecular basis and the functional relevance of this flexibility is an important goal of future research projects, but it will require innovative methodological approaches. Overall, our findings open new perspectives to understand the molecular mechanism by which Tra1 modulates SAGA enzymatic activities upon binding transcription activators.
Recent seminal work established that complexes are generally assembled by ordered pathways that appear evolutionarily conserved1. Biochemical analyses of SAGA in various mutants suggested that the last steps of SAGA assembly occur through an ordered pathway. Indeed, Spt20 is required for both Tra1 and DUB incorporation into SAGA, while Tra1 stabilises the DUB, but not Spt20. Conversely, the DUB module does not regulate Spt20 or Tra1 assembly. Finally, monitoring the fate of the DUB component Sgf11 upon Tra1 de novo synthesis supports a model in which Tra1 interacts with Spt20 and then promotes incorporation of the DUB module (Fig. 8f). However, Tra1 is presumably not directly recruiting the DUB module into SAGA. Recent structural analyses indicate that Tra1 does not stably contact any DUB component in most mature SAGA conformations12. Rather, Tra1 might stabilise DUB incorporation during the assembly process, either through transient direct interaction or indirectly, by inducing a conformational change within Spt20 that allows SAGA-DUB interactions. Combining our work with previous structural and biochemical analyses suggests that Spt20 directly contacts the DUB anchor subunit, Sgf73, although a higher resolution structure of SAGA is needed to validate this hypothesis.
To conclude, these results contribute to our understanding of the mechanisms and pathways by which multifunctional transcription complexes assemble, which is essential to characterise their structural organisation and regulatory roles. The current model for Tra1 function postulates that it transmits the transactivation signal from promoter-bound transcription factors to SAGA and NuA4 activities, which have critical roles in both basal and inducible RNA polymerase II transcription. Along this line, we noted that only a small number of genes require Tra1, Tra2 and Spt20 for their expression in S. pombe (Figs. 1a, b, 5e, f, 6g–i, and Supplementary Fig. 3). However, our RNA-seq analyses measured transcript levels at steady state. Recent work using nascent RNA-seq demonstrated that SAGA has a much more global role on RNA polymerase II transcription in S. cerevisiae49. Therefore, it will be important for future studies to use such methodological approaches, in order to determine the genome-wide effects of SAGA and NuA4 on transcription rates in S. pombe. Our work opens exciting prospects for the characterisation of Tra1 exact roles during transcription initiation and of its specific contribution to SAGA and NuA4 regulatory activities.
Methods
Yeast manipulation and growth conditions
Standard culture media and genetic manipulations were used. S. cerevisiae strains were grown in YPD at 30 °C to mid-log phase (~1 × 107 cells per ml). S. pombe strains were grown in either rich (YES) or minimal (EMM) media at 32 °C to mid-log phase (~0.5 × 107 cells per ml). Proliferation assays were performed by inoculating single colonies in liquid media and counting the number of cells at different time points. For longer time courses, cultures were diluted to keep cells in constant exponential growth. Cell viability was assessed using 10 µL of the colorimetric dye methylene blue (319112, Sigma), which was incubated with a 50 µL suspension of exponentially growing yeast cells resuspended in PBS 1×. The number of blue-coloured dead cells was counted under a light microscope. For auxin-inducible targeted protein degradation (AID), cells were grown at 25 °C and treated with either 0.5 mM indol-3-acetic acid (IAA, I2886, Sigma) or ethanol. For CreER-loxP-mediated recombination, cells were treated with either 1 µM β-estradiol (E2758, Sigma) or DMSO, for either 18 h (tti2-CKO strains) or 21 h (tra2-CKO and control creER strains), unless otherwise indicated.
Strain construction
All S. pombe and S. cerevisiae strains used are listed in Supplementary Table 4 and were constructed by standard procedures, using either chemical transformation or genetic crosses. Strains with gene deletions, truncations or C-terminally epitope-tagged proteins were constructed by PCR-based gene targeting of the respective open-reading frame (ORF) with kanMX6, natMX6 or hphMX6 cassettes, amplified from pFA6a backbone plasmids50,51. For insertion of loxP sites, the same resistance cassettes were amplified from the pUG6 or pUG75 plasmids (Euroscarf #P30114, and #P30671, respectively)52. Constructions of point mutations, internal deletions or domain swaps in spt20 and tra1 were performed using a ura4 cassette in a two step in vivo site-directed mutagenesis procedure53. Alternatively, CRISPR-Cas9-mediated genome editing was used, as described54, for example for marker-less N-terminal epitope tagging of tra1. DNA fragments used for homologous recombination were generated by PCR, Gibson assembly cloning (kit E2611L, New England Biolabs), or gene synthesis. Cloning strategies and primers were designed using the online fission yeast database, PomBase55. All relevant primer sequences are listed in Supplementary Table 5. Transformants were screened for correct integration by PCR and, when appropriate, verified by Sanger sequencing or Western blotting. For each transformation, 2–4 individual clones were purified and analysed.
Because the tti2 gene is essential for viability in S. pombe22, C-terminal epitope tagging was performed in diploids, to generate heterozygous alleles. Their sporulation demonstrated that all C-terminally tagged Tti2 strains grew similarly to wild-type controls in all conditions that were tested.
Plasmid construction
Auxin-inducible degron (AID) tagging was performed using a plasmid, DHB137, which we constructed by inserting three HA epitopes in fusion with the three copies of the mini-AID sequence from pMK15156. V5-PK tagging was performed using a plasmid, DHB123, which we constructed by inserting three V5 epitopes 5′ to the hphMX6 cassette into pFA6a-hphMX6 (Euroscarf #P30438)51. For GST pull-down assays, DNA fragments comprising either nucleotides +925 to +1054 from the S. pombe spt20 ORF, encoding residues Asp282 to Ala324, or nucleotides +1402 to +1611 from the S. cerevisiae SPT20 ORF, encoding residues Met468 to Ala537, were synthesised and amplified. Each product was then subcloned into pGEX-4T2 (GE Healthcare Life Sciences), 3′ and in frame to the GST coding sequence, using the Gibson assembly kit (E2611L, New England Biolabs), to generate the DHB179 and DHB193 plasmids, respectively.
RT-qPCR
Reverse transcription and quantitative PCR analyses of cDNA were performed using RNA extracted from 50 mL of exponentially growing cells, as described57, and according to the MIQE guidelines58. Briefly, the total RNA was purified using hot, acidic phenol, and contaminating DNA was removed by DNase I digestion, using the TURBO DNA-free™ kit (AM1907, Ambion). One microgram of RNA was then reverse-transcribed (RT) at 55 °C with random hexanucleotide primers, using the SuperScript III First-Strand System (18080051, Thermo Fisher Scientific). Fluorescence-based quantitative PCR was performed with SYBR Green and used to calculate relative cDNA quantities, from the slope produced by standard curves for each primer pair, generated in each experiment. DNase-treated RNA samples were used as controls for the presence of genomic DNA contaminants. Standard curve slopes were comprised between −3.5 (90% efficiency) and −3.15 (110% efficiency), with an r2 > 0.9. All primer sequences are listed in Supplementary Table 5.
Protein extraction
Protein extracts were prepared as described57. Briefly, 10–25 mL cultures of exponentially growing cells were homogenised by glass bead-beating in a FastPrep (MP Biomedicals). Proteins were extracted using either a standard lysis buffer (WEB: 40 mM HEPES-NaOH pH 7.4, 350 mM NaCl, 0.1% NP40 and 10% glycerol) or trichloroacetic acid (TCA) precipitation. WEB was supplemented with protease inhibitors, including complete EDTA-free cocktails tablets (04693132001, Roche), 1 mM PMSF (P7626, Sigma), 1 μg per ml bestatin (B8385, Sigma) and 1 μg per ml pepstatin A (P5318, Sigma). Protein concentrations were measured by the Bradford method. Ponceau red or Coomassie blue staining were used to normalise for total protein levels across samples.
Western blotting and antibodies
Western blotting was performed using the following antibodies: peroxidase-anti-peroxidase (PAP) (P1291, Sigma, 1:2000); anti-Calmodulin binding protein (CBP) (RCBP-45A-Z, ICLab, 1:500); anti-tubulin (B-5–1–2, Sigma, 1:5000); anti-FLAG (M2, F1804, Sigma, 1:1000); anti-MYC (9E10, Agro-Bio LC; 9E11, ab56, Abcam, 1:1000; or rabbit polyclonal ab9106, Abcam, 1:1000); anti-V5 (SV5-Pk1, AbD Serotec, 1:1000); anti-HA (16B12, Ozyme; rabbit polyclonal, ab9110, Abcam, 1:1000). Protein concentrations were measured by the Bradford method and used to load equal amounts of proteins across samples. Quantification of signal intensity was performed using staining, film exposure or digital acquisition that were within the linear range of detection, as verified by loading serial dilutions of one sample, and analysed using ImageJ.
Chromatin immunoprecipitation
ChIP experiments were performed as previously described11. Briefly, cell cultures were cross-linked in 1% formaldehyde for 30 min. Cells were then broken using a FastPrep (MP Biomedicals), and the chromatin fraction was sheared to 200–500 bp fragments using a Branson sonicator for nine cycles (10 s ON, 50 s OFF) at an amplitude of 20%. For immunoprecipitation (IP), 3–5 µg of anti-HA (16B12) or anti-Myc antibodies (9E11) were incubated overnight at 4 °C with the chromatin extracts and then coupled with 50 µl of protein-G-sepharose beads (GE17–0618–01, Sigma) during 4 h at 4 °C. ChIP DNA was quantified by fluorescence-based quantitative PCR using SYBR Green, as described for RT-qPCR analysis. Input (IN) samples were diluted 200-fold, while IP samples were diluted threefold. Relative occupancy levels were determined by dividing the IP by the IN value (IP/IN) for each amplicon. To determine the specificity of enrichment of the tagged protein, the corresponding untagged control samples were included in each ChIP experiment. All primer sequences are listed in Supplementary Table 5.
Affinity purification
Protein complexes were purified by the tandem affinity purification (TAP) method, as described previously39,59, with minor modifications. One to four liters of exponentially growing cells were harvested, snap-frozen as individual droplets and grinded in liquid nitrogen using a Freezer/Mill® (Spex SamplePrep). Protein extraction was performed in either WEB buffer or CHAPS-containing lysis buffer (CLB) buffer (50 mM HEPES-NaOH pH 7.4, 300 mM NaCl, 5 mM CHAPS, 0.5 mM DTT), supplemented with protease and phosphatase inhibitors. Following purifications, 10% of 2 mM EGTA eluates were concentrated and separated on 4–20% gradient SDS-polyacrylamide Tris-glycine gels (Biorad). Total protein content was visualised by silver staining, using the SilverQuest kit (LC6070, Thermo Fisher Scientific). For quantitative mass spectrometry analyses, 40% of 2 mM EGTA eluates were precipitated with TCA and analysed by mass spectrometry (MS). A downscaled version of the TAP procedure was used for standard co-immunoprecipitation followed by western blot analysis, as described previously57.
Recombinant GST and GST-HIT proteins were produced by IPTG induction of transformed BL21 Rosetta strains and purified on 100 μl of Glutathione Sepharose 4B beads (17075601, GE Healthcare Life Sciences), for 4–5 h at 4 °C. After washing, beads were further incubated overnight at 4 °C with 5–10 mg of S. pombe protein extracts prepared in WEB lysis buffer, before analysis by Coomassie blue staining and western blotting.
Mass spectrometry and data analysis
Dry TCA precipitates from TAP eluates were denatured, reduced and alkylated. Briefly, each dry TCA precipitate sample was dissolved in 89 μL of TEAB 100 mM, and 1 μL of DTT 1 M was added before incubation for 30 min at 60 °C. A volume of 10 μL of IAA 0.5 M was added (incubation for 30 min in the dark). Enzymatic digestion was performed by addition of 1 μg trypsin (Gold, Promega, Madison USA) in TEAB 100 mM and incubation overnight at 30 °C. After completing the digestion step, peptides were purified and concentrated using OMIX Tips C18 reverse-phase resin (Agilent Technologies Inc.) according to the manufacturer’s specifications. Peptides were dehydrated in a vacuum centrifuge.
Samples were resuspended in 9 μL formic acid (0.1%, buffer A), and 2 µL were loaded onto a 15 cm reversed phase column (75 mm inner diameter, Acclaim Pepmap 100® C18, Thermo Fisher Scientific) and separated with an Ultimate 3000 RSLC system (Thermo Fisher Scientific) coupled to a Q Exactive Plus (Thermo Fisher Scientific) via a nano-electrospray source, using a 143-min gradient of 2–40% of buffer B (80% ACN, 0.1% formic acid) and a flow rate of 300 nl per min.
MS/MS analyses were performed in a data-dependent mode. Full scans (375–1500 m z−1) were acquired in the Orbitrap mass analyser with a 70,000 resolution at 200 m z−1. For the full scans, 3 × 106 ions were accumulated within a maximum injection time of 60 ms and detected in the Orbitrap analyser. The 12 most intense ions with charge states ≥ 2 were sequentially isolated to a target value of 1 × 105 with a maximum injection time of 45 ms and fragmented by HCD (Higher-energy collisional dissociation) in the collision cell (normalised collision energy of 28%) and detected in the Orbitrap analyser at 17,500 resolution.
Raw spectra were processed using the MaxQuant environment (v1.5.0.0 or v1.5.5.1)60 and Andromeda for database search with label-free quantification (LFQ), match between runs and the iBAQ algorithm enabled61. The MS/MS spectra were matched against the UniProt reference proteome (Proteome ID UP000002485) of S. pombe (strain 972 / ATCC 24843) (Fission yeast) (release 2017_10, https://www.uniprot.org/), 250 frequently observed contaminants, as well as reversed sequences of all entries. Different release versions were used, depending on the date of analysis (Supplementary Table 6). Enzyme specificity was set to trypsin/P, and the search included cysteine carbamidomethylation as a fixed modification and oxidation of methionine, and acetylation (protein N-term) and/or phosphorylation of Ser, Thr, Tyr residue (STY) as variable modifications. Up to two missed cleavages were allowed for protease digestion. FDR was set at 0.01 for peptides and proteins and the minimal peptide length at 7.
The relative abundance of proteins identified in each affinity purification was calculated as described62. Briefly, label-free quantification (LFQ) intensity values were transformed to a base 2 logarithmic scale (Log2), to fit the data to a Gaussian distribution and enable the imputation of missing values. For Tti2 interactome analysis (Supplementary Data 1), normalised LFQ intensities were compared between replicates, using a 1% permutation-based false discovery rate (FDR) in a two-tailed Student’s t test. The threshold for significance was set to 1 (fold change = 2), based on the ratio between TAP and no-TAP samples and the FDR. The relative abundance of subunits in each purification eluate was obtained by dividing the LFQ intensity of that interactor (prey) to the LFQ intensity of the TAP purified protein (bait). For clarity purposes, this ratio was further normalised to that obtained in control strains in Fig. 5, Fig. 6, Fig. 7 and Supplementary Fig. 9.
RNA-seq and data analysis
Each growth condition or yeast strain was analysed in triplicate. RNA was extracted from 50 mL of exponentially growing cells RNA using TRIzol reagent (15596018, Thermo Fisher Scientific). DNA was removed by DNase I digestion, using the TURBO DNA-free™ kit (AM1907, Ambion), and RNA was cleaned using the RNeasy Mini kit (74104, Qiagen). The total RNA quality and concentration was determined using an Agilent Bioanalyzer. Transcripts were purified by polyA-tail selection. Stranded dual-indexed cDNA libraries were constructed using the Illumina TruSeq Stranded mRNA Library Prep kit. Library size distribution and concentration were determined using an Agilent Bioanalyzer. 48 libraries were sequenced in one lane of an Illumina HiSeq 4000, with 1 × 50 bp single reads, at Fasteris SA (Plan-les-Ouates, Switzerland). After demultiplexing according to their index barcode, the total number of reads ranged from 6 to 10 million per library.
Adapter sequences were trimmed from reads in the Fastq sequence files. Reads were aligned using HISAT263, with strand-specific information (–rna-strandness R) and otherwise default options. For all 48 samples, the overall alignment rate was over 95%, including over 90% of reads mapping uniquely to the S. pombe genome. Reads were then counted for gene and exon features using htseq-count64 in union mode (–mode union), reverse stranded (–stranded Reverse), and a minimum alignment quality of 10 (–minaqual 10). For all samples, over 95% of reads were assigned to a feature (–type gene). Variance-mean dependence was estimated from count tables and tested for differential expression based on a negative binomial distribution, using DESeq265. Pairwise comparison or one-way analysis of variance were run with a parametric fit and genotype as the source of variation (factor: mutant or control). Hierarchical clustering of genes which expression changes in control creER, Tti2-depleted, Tra2-depleted and Tra1 knockout cells was performed on the Log2 fold changes calculated using DESeq2. Genes were clustered based on Pearson correlation distance measurements and using the complete linkage method, in Cluster 3.066. All other computational analyses were run either on R (version 3.6.0), using publicly available packages, or on the Galaxy web platform using the public server at usegalaxy.org67.
Statistical analysis
All statistical tests were performed using either R (version 3.6.0) for RNA-seq data or GraphPad Prism for proteomic data. All other experiments were analysed using GraphPad Prism. t tests were used when comparing two means. One-way or two-way analyses of variance (ANOVA) were performed for comparing more than two means, across one (for example “genotype”) or two distinct variables (for example “genotype” as a between-subject factor and “time” as a within-subject factor). One-way and two-way ANOVAs were followed by Tukey and Bonferroni post-hoc pairwise comparisons, respectively. An α level of 0.01 was used a priori for all statistical tests, except otherwise indicated. Comparisons that are statistically significant (P ≤ 0.01) are marked with one asterisk.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
We acknowledge Kerstin Wagner and Elsa Cesari for invaluable technical assistance and all members of the Helmlinger laboratory for helpful suggestions and discussions. We thank Patrick Schultz and Adam Ben Shem for kindly sharing results before their publication. We thank Fred Winston for critical reading of the manuscript and sharing S. cerevisiae strains. We are grateful to Robin Allshire, Charles Hoffman, Hisao Masukata, and Paul Russell for sharing S. pombe strains. A.E.V. is a recipient of a post-doctoral fellowship from the Fondation pour la Recherche Médicale (SPF20130526854). D.T. is a recipient of a graduate fellowship from the French Ministry for Research and Higher Education (MESR), supported by the Labex EpiGenMed, an « Investissements d’avenir » program (ANR-10-LABX-12–01). This work was supported by funds from the CNRS (ATIP-Avenir), the FP7 Marie Curie Actions (FP7-PEOPLE-2012-CIG/COACTIVATOR), and the Agence Nationale de la Recherche (ANR-15-CE12–0009–01 and ANR-15-CE11–0022–03) to D.H.
Author contributions
A.E.V., D.T. and C.F. designed, performed and analysed all experiments, except RNA-seq analyses (D.H.) and quantitative LC-MS/MS experiments (M.S.); D.H. designed the study, acquired funding and supervised the project; D.H. wrote the paper with input from all authors.
Data availability
The raw sequencing data reported in this publication have been deposited in NCBI Gene Expression Omnibus68 and are accessible through GEO Series accession number GSE128448. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE69 partner repository with the data set identifier PXD013256. Supplementary Table 6 cross-references all MaxQuant results from each figure or table with the raw data files. All other relevant data supporting the key findings of this study are available within the article and its Supplementary Information files or from the corresponding author upon reasonable request. The source data underlying all figures and supplementary figures, including uncropped versions of all gels and blots and the raw data of all reported graphs, are provided as a Source Data file. A reporting summary is available as a supplementary information file.
Competing interests
The authors declare no competing interests.
Footnotes
Peer review information Nature Communications thanks Steven Hahn, Teck Yew Low and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information is available for this paper at 10.1038/s41467-019-13243-w.
References
- 1.Marsh JA, Teichmann SA. Structure, dynamics, assembly, and evolution of protein complexes. Annu. Rev. Biochem. 2015;84:551–575. doi: 10.1146/annurev-biochem-060614-034142. [DOI] [PubMed] [Google Scholar]
- 2.Helmlinger D, Tora L. Sharing the SAGA. Trends Biochem. Sci. 2017;42:850–861. doi: 10.1016/j.tibs.2017.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Koutelou E, Hirsch CL, Dent SY. Multiple faces of the SAGA complex. Curr. Opin. Cell Biol. 2010;22:374–382. doi: 10.1016/j.ceb.2010.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Spedale G, Timmers HT, Pijnappel WW. ATAC-king the complexity of SAGA during evolution. Genes Dev. 2012;26:527–541. doi: 10.1101/gad.184705.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lu PY, Lévesque N, Kobor MS. NuA4 and SWR1-C: two chromatin-modifying complexes with overlapping functions and components. Biochem. Cell Biol. 2009;87:799–815. doi: 10.1139/O09-062. [DOI] [PubMed] [Google Scholar]
- 6.Helmlinger D. New insights into the SAGA complex from studies of the Tra1 subunit in budding and fission yeast. Transcription. 2012;3:13–18. doi: 10.4161/trns.3.1.19271. [DOI] [PubMed] [Google Scholar]
- 7.Cheung ACM, Díaz-Santín LM. Share and share alike: the role of Tra1 from the SAGA and NuA4 coactivator complexes. Transcription. 2018;00:1–7. doi: 10.1080/21541264.2018.1530936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 1998;94:363–374. doi: 10.1016/S0092-8674(00)81479-8. [DOI] [PubMed] [Google Scholar]
- 9.Saleh A, et al. Tra1p is a component of the yeast Ada·Spt transcriptional regulatory complexes. J. Biol. Chem. 1998;273:26559–26565. doi: 10.1074/jbc.273.41.26559. [DOI] [PubMed] [Google Scholar]
- 10.Vassilev A, et al. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol. Cell. 1998;2:869–875. doi: 10.1016/S1097-2765(00)80301-9. [DOI] [PubMed] [Google Scholar]
- 11.Helmlinger D, et al. Tra1 has specific regulatory roles, rather than global functions, within the SAGA co-activator complex. EMBO J. 2011;30:2843–2852. doi: 10.1038/emboj.2011.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sharov G, et al. Structure of the transcription activator target Tra1 within the chromatin modifying complex SAGA. Nat. Commun. 2017;8:1556. doi: 10.1038/s41467-017-01564-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang X, Ahmad S, Zhang Z, Côté J, Cai G. Architecture of the Saccharomyces cerevisiae NuA4/TIP60 complex. Nat. Commun. 2018;9:1147. doi: 10.1038/s41467-018-03504-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Takai H, Wang RC, Takai KK, Yang H, de Lange T. Tel2 regulates the stability of PI3K-related protein kinases. Cell. 2007;131:1248–1259. doi: 10.1016/j.cell.2007.10.052. [DOI] [PubMed] [Google Scholar]
- 15.Anderson CM, et al. Tel2 mediates activation and localization of ATM/Tel1 kinase to a double-strand break. Genes Dev. 2008;22:854–859. doi: 10.1101/gad.1646208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Takai H, Xie Y, de Lange T, Pavletich NP. Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes Dev. 2010;24:2019–2030. doi: 10.1101/gad.1956410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hurov KE, Cotta-Ramusino C, Elledge SJ. A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev. 2010;24:1939–1950. doi: 10.1101/gad.1934210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kaizuka T, et al. Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J. Biol. Chem. 2010;285:20109–20116. doi: 10.1074/jbc.M110.121699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Izumi N, Yamashita A, Hirano H, Ohno S. Heat shock protein 90 regulates phosphatidylinositol 3-kinase-related protein kinase family proteins together with the RUVBL1/2 and Tel2-containing co-factor complex. Cancer Sci. 2012;103:50–57. doi: 10.1111/j.1349-7006.2011.02112.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hayashi T, et al. Rapamycin sensitivity of the Schizosaccharomyces pombe tor2 mutant and organization of two highly phosphorylated TOR complexes by specific and common subunits. Genes Cells. 2007;12:1357–1370. doi: 10.1111/j.1365-2443.2007.01141.x. [DOI] [PubMed] [Google Scholar]
- 21.Shevchenko A, et al. Chromatin central: towards the comparative proteome by accurate mapping of the yeast proteomic environment. Genome Biol. 2008;9:R167. doi: 10.1186/gb-2008-9-11-r167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Inoue H, et al. CK2 phospho-independent assembly of the Tel2-associated stress-signaling complexes in Schizosaccharomyces pombe. Genes Cells. 2017;22:59–70. doi: 10.1111/gtc.12454. [DOI] [PubMed] [Google Scholar]
- 23.Genereaux J, et al. Genetic evidence links the ASTRA protein chaperone component Tti2 to the SAGA transcription factor Tra1. Genetics. 2012;191:765–780. doi: 10.1534/genetics.112.140459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Brown CE, et al. Recruitment of HAT complexes by direct activator interactions with the ATM-related Tra1 subunit. Science. 2001;292:2333–2337. doi: 10.1126/science.1060214. [DOI] [PubMed] [Google Scholar]
- 25.Bhaumik SR, Green MR. SAGA is an essential in vivo target of the yeast acidic activator Gal4p. Genes Dev. 2001;15:1935–1945. doi: 10.1101/gad.911401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bhaumik SR, Raha T, Aiello DP, Green MR. In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer. Genes Dev. 2004;18:333–343. doi: 10.1101/gad.1148404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Fishburn J, Mohibullah N, Hahn S. Function of a eukaryotic transcription activator during the transcription cycle. Mol. Cell. 2005;18:369–378. doi: 10.1016/j.molcel.2005.03.029. [DOI] [PubMed] [Google Scholar]
- 28.Reeves WM, Hahn S. Targets of the Gal4 transcription activator in functional transcription complexes. Mol. Cell. Biol. 2005;25:9092–9102. doi: 10.1128/MCB.25.20.9092-9102.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Herbig E, et al. Mechanism of mediator recruitment by tandem Gcn4 activation domains and three Gal11 activator-binding domains. Mol. Cell. Biol. 2010;30:2376–2390. doi: 10.1128/MCB.01046-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Knutson BA, Hahn S. Domains of Tra1 important for activator recruitment and transcription coactivator functions of SAGA and NuA4 complexes. Mol. Cell. Biol. 2011;31:818–831. doi: 10.1128/MCB.00687-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pal M, et al. Structural basis for phosphorylation-dependent recruitment of Tel2 to Hsp90 by Pih1. Structure. 2014;22:805–818. doi: 10.1016/j.str.2014.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Aligue R, Akhavan-Niak H, Russell P. A role for Hsp90 in cell cycle control: Wee1 tyrosine kinase activity requires interaction with Hsp90. EMBO J. 1994;13:6099–6106. doi: 10.1002/j.1460-2075.1994.tb06956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Alaamery MA, Hoffman CS. Schizosaccharomyces pombe Hsp90/Git10 is required for glucose/cAMP signaling. Genetics. 2008;178:1927–1936. doi: 10.1534/genetics.107.086165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Boudreault AA, et al. Yeast enhancer of polycomb defines global Esa1-dependent acetylation of chromatin. Genes Dev. 2003;17:1415–1428. doi: 10.1101/gad.1056603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Auger A, et al. Eaf1 is the platform for NuA4 molecular assembly that evolutionarily links chromatin acetylation to ATP-dependent exchange of histone H2A variants. Mol. Cell. Biol. 2008;28:2257–2270. doi: 10.1128/MCB.01755-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Han Y, Luo J, Ranish J, Hahn S. Architecture of the Saccharomyces cerevisiae SAGA transcription coactivator complex. EMBO J. 2014;33:2534–2546. doi: 10.15252/embj.201488638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Setiaputra D, et al. Conformational flexibility and subunit arrangement of the modular yeast Spt-Ada-Gcn5 acetyltransferase complex. J. Biol. Chem. 2015;290:10057–10070. doi: 10.1074/jbc.M114.624684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Setiaputra D, et al. Molecular architecture of the essential yeast histone acetyltransferase complex NuA4 redefines its multi-modularity. Mol. Cell. Biol. 2018;38:1–15. doi: 10.1128/MCB.00570-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Helmlinger D, et al. The S. pombe SAGA complex controls the switch from proliferation to sexual differentiation through the opposing roles of its subunits Gcn5 and Spt8. Genes Dev. 2008;22:3184–3195. doi: 10.1101/gad.1719908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wu P-YJY, Winston F. Analysis of Spt7 function in the Saccharomyces cerevisiae SAGA coactivator complex. Mol. Cell. Biol. 2002;22:5367–5379. doi: 10.1128/MCB.22.15.5367-5379.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lee KK, et al. Combinatorial depletion analysis to assemble the network architecture of the SAGA and ADA chromatin remodeling complexes. Mol. Syst. Biol. 2011;7:503. doi: 10.1038/msb.2011.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nagy Z, et al. The human SPT20-containing SAGA complex plays a direct role in the regulation of endoplasmic reticulum stress-induced genes. Mol. Cell. Biol. 2009;29:1649–1660. doi: 10.1128/MCB.01076-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Köhler A, Schneider M, Cabal GG, Nehrbass U, Hurt E. Yeast Ataxin-7 links histone deubiquitination with gene gating and mRNA export. Nat. Cell Biol. 2008;10:707–715. doi: 10.1038/ncb1733. [DOI] [PubMed] [Google Scholar]
- 44.Antonova SV, et al. Chaperonin CCT checkpoint function in basal transcription factor TFIID assembly. Nat. Struct. Mol. Biol. 2018;25:1119–1127. doi: 10.1038/s41594-018-0156-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Imseng S, Aylett CH, Maier T. Architecture and activation of phosphatidylinositol 3-kinase related kinases. Curr. Opin. Struct. Biol. 2018;49:177–189. doi: 10.1016/j.sbi.2018.03.010. [DOI] [PubMed] [Google Scholar]
- 46.Yang H, et al. 4.4 Å resolution Cryo-EM structure of human mTOR complex 1. Protein Cell. 2016;7:878–887. doi: 10.1007/s13238-016-0346-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Karuppasamy, M. et al. Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2. Nat. Commun. 8, 1279 (2017). [DOI] [PMC free article] [PubMed]
- 48.Herceg Z, et al. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat. Genet. 2001;29:206–211. doi: 10.1038/ng725. [DOI] [PubMed] [Google Scholar]
- 49.Baptista T, et al. SAGA is a general cofactor for RNA polymerase II transcription. Mol. Cell. 2017;68:130–143.e5. doi: 10.1016/j.molcel.2017.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bahler J, et al. Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast. 1998;14:943–951. doi: 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
- 51.Hentges P, Van Driessche B, Tafforeau L, Vandenhaute J, Carr AM. Three novel antibiotic marker cassettes for gene disruption and marker switching in Schizosaccharomyces pombe. Yeast. 2005;22:1013–1019. doi: 10.1002/yea.1291. [DOI] [PubMed] [Google Scholar]
- 52.Gueldener U, Heinisch J, Koehler GJ, Voss D, Hegemann JH. A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast. Nucleic Acids Res. 2002;30:e23. doi: 10.1093/nar/30.6.e23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Storici F, Lewis LK, Resnick MA. In vivo site-directed mutagenesis using oligonucleotides. Nat. Biotechnol. 2001;19:773–776. doi: 10.1038/90837. [DOI] [PubMed] [Google Scholar]
- 54.Zhang X-R, He J-B, Wang Y-Z, Du L-L. A cloning-free method for CRISPR/Cas9-mediated genome editing in fission yeast. G3 (Bethesda). 2018;8:g3.200164.2018. doi: 10.1534/g3.118.200164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lock A, et al. PomBase 2018: user-driven reimplementation of the fission yeast database provides rapid and intuitive access to diverse, interconnected information. Nucleic Acids Res. 2019;47:D821–D827. doi: 10.1093/nar/gky961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kubota T, Nishimura K, Kanemaki MT, Donaldson AD. The Elg1 replication factor C-like complex functions in PCNA unloading during DNA replication. Mol. Cell. 2013;50:273–280. doi: 10.1016/j.molcel.2013.02.012. [DOI] [PubMed] [Google Scholar]
- 57.Laboucarié T, et al. TORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availability. EMBO Rep. 2017;16:202–212. doi: 10.15252/embr.201744942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Bustin SA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009;55:611–622. doi: 10.1373/clinchem.2008.112797. [DOI] [PubMed] [Google Scholar]
- 59.Rigaut G, et al. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999;17:1030–1032. doi: 10.1038/13732. [DOI] [PubMed] [Google Scholar]
- 60.Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367–1372. doi: 10.1038/nbt.1511. [DOI] [PubMed] [Google Scholar]
- 61.Cox J, et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 2011;10:1794–1805. doi: 10.1021/pr101065j. [DOI] [PubMed] [Google Scholar]
- 62.Smits AH, Jansen PWTC, Poser I, Hyman AA, Vermeulen M. Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic Acids Res. 2013;41:e28. doi: 10.1093/nar/gks941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods. 2015;12:357–360. doi: 10.1038/nmeth.3317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Anders S, Pyl PT, Huber W. HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–169. doi: 10.1093/bioinformatics/btu638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1–21. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.de Hoon MJL, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004;20:1453–1454. doi: 10.1093/bioinformatics/bth078. [DOI] [PubMed] [Google Scholar]
- 67.Afgan E, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46:W537–W544. doi: 10.1093/nar/gky379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–210. doi: 10.1093/nar/30.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450. doi: 10.1093/nar/gky1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Buchan DWA, Minneci F, Nugent TCO, Bryson K, Jones DT. Scalable web services for the PSIPRED protein analysis workbench. Nucleic Acids Res. 2013;41:349–357. doi: 10.1093/nar/gkt381. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw sequencing data reported in this publication have been deposited in NCBI Gene Expression Omnibus68 and are accessible through GEO Series accession number GSE128448. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE69 partner repository with the data set identifier PXD013256. Supplementary Table 6 cross-references all MaxQuant results from each figure or table with the raw data files. All other relevant data supporting the key findings of this study are available within the article and its Supplementary Information files or from the corresponding author upon reasonable request. The source data underlying all figures and supplementary figures, including uncropped versions of all gels and blots and the raw data of all reported graphs, are provided as a Source Data file. A reporting summary is available as a supplementary information file.